Significant changes in the tau A0 and A3 alleles in progressive supranuclear palsy and improved genotyping by silver detection

Archives of Neurology

Volumn 55, Issue 8, 1998, Pages 1122-1124

  Oliva, Rafael ^a,b   Tolosa, Eduardo ^b   Ezquerra, Mario ^a   Molinuevo, Jose Luis ^b   Valldeoriola, Francesc ^b   Burguera, Juan ^c   Calopa, Matilde ^d   Villa, Marga ^a   Ballesta, Francisca ^a  

^a Inst Investigacions Biomediques A   (Spain)

^b HOSPITAL CLÍNIC   (Spain)

^c HOSPITAL UNIVERSITARIO LA FE   (Spain)

^d HOSPITAL UNIVERSITARI DE BELLVITGE   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN E3; DINUCLEOTIDE; TAU PROTEIN;

AGED; ARTICLE; CELL INCLUSION; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; GENE FREQUENCY; GENETIC POLYMORPHISM; GENOTYPE; HOMOZYGOTE; HUMAN; NEUROFIBRILLARY TANGLE; PRIORITY JOURNAL; PROGRESSIVE SUPRANUCLEAR PALSY; PROTEIN AGGREGATION; RISK FACTOR; SILVER STAINING; SPAIN;

AGED; ALLELES; CASE-CONTROL STUDIES; DNA PRIMERS; FEMALE; GENOTYPE; HUMANS; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC; SUPRANUCLEAR PALSY, PROGRESSIVE; TAU PROTEINS;

EID: 0031869343     PISSN: 00039942     EISSN: None     Source Type: Journal    
DOI: 10.1001/archneur.55.8.1122     Document Type: Article

References (19)

1. Golbe LI, Davis PH. Progressive supranuclear palsy. In: Jankovic JI, Tolosa E, eds. Parkinson Disease and Movement Disorders. Baltimore, Md: Williams & Wilkins; 1993:145-161.
2. Lees AJ. The Steele-Richardson-Olszewsky syndrome (progressive supranuclear palsy). In: Marden DC, Fabri S, eds. Movement Disorders. Vol 2. Newton, Mass: Butterworth-Heinemann; 1997:272-287.
3. Tolosa E, Valldeoriola F, Marti MJ. Clinical diagnosis and diagnostic entera of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome). J Neural Transm. 1994;42(suppl):15-31.
4. Kosik KS. Tau protein and neurodegeneration. Mol Neurobiol. 1990;4:171-79.
5. Haw JJ, Daniel SE, Dickson D, et al. Preliminary NINDS neuropathologic criteria for Steele-Richardson-Olszewski syndrome (progressive supranuclear palsy). Neurology 1994;44:2015-2019.
6. Gearing M, Olson D, Watts R, Mirra S. Progressive supranuclear palsy: neuropathological and clinical heterogeneity. Neurology. 1994;44:1015-1024.
7. Collins SJ, Ahlskog JE, Parisi JE, Maraganore DM. Progressive supranuclear palsy: neuropathologically based diagnostic clinical criteria. J Neurol Neurosurg Psychiatry. 1995;58:167-173.
8. Blesa R, Adroer R, Santacruz P, Ascaso C, Tolosa E, Oliva R. High apolipoprotein E ∈4 allele frequency in age related memory decline. Ann Neurol. 1996;39:548-551.
9. Adroer R, Santacruz P, Blesa R, Lopez-Pousa S, Ascaso C, Oliva R. Apolipoprotein E4 allele frequency in Spanish Alzheimer and control cases. Neurosci Lett. 1995;189:182-186.
10. Feany MB, Dickson DW. Neurodegenerative disorders with extensive tau pathology: a comparative study and review. Ann Neurol. 1996;40:139-148.
11. Tetrud JW, Golbe LI, Farmer PM, Forno LS. Autopsy-proven supranuclear palsy in two siblings. Neurology. 1996;46:931-934.
12. deYebenes JG, Sarasa JL, Daniel SE, Lees AJ. Familial progressive supranuclear palsy:. description of a pedigree and review of the literature. Brain. 1995;118:1095-1103.
13. 13m Arai H, Higuchi S, Muramatsu T, Matsushita S, Itabashi S, Sasak H. Lack of association of apolipoprotein E ∈4 allele with progressive supranuclear palsy. Neurodegeneration. 1996;5:194-195.
14. Anouti A, Schmidt K, Lyons KE, et al. Normal distribution of apolipoprotein E alleles in progressive supranuclear palsy. Neurology. 1996;46:1156-1157.
15. Conrad C, Andreadis A, Trojanowsky JQ, et al. Genetic evidence for the involvement of τ in progressive supranuclear palsy. Ann Neurol. 1997;41:277-281.
16. Litvan I, Agid Y, Calne D, et al. Clinical research criteria for the diagnosis of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome): report of the NINDS-SPSP International Workshop. Neurology. 1996;47:1-9.
17. Tolosa E, Valldeoriola F, Cruz-Sánchez F. Progressive supranuclear palsy: clinical and pathological diagnosis. Eur J Neurol. 1995;2:259-273.
18. Bassam BJ, Caetano-Anollés G, Gresshoff PM. Fast and sensitive silver staining of DNA in polyacrylamide gels. Anal Biochem. 1991;196:80-83.
19. Strittmatter WJ, Saunders AM, Schmechel D, et al. Apolipoprotein E: high-avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer's disease. Proc Natl Acad Sci U S A. 1993;90:1977-1981.